BP Logix Appoints Dr. Robert Kaper to Strategic Advisory Board to Accelerate Innovation in Life Sciences

Audio By Carbonatix

SAN DIEGO--(BUSINESS WIRE)--Aug 12, 2025--

In a move to strengthen its ties to the life sciences industry, BP Logix has appointed Dr. Robert Kaper to its Strategic Advisory Board. Dr. Kaper brings more than 30 years of global leadership experience in Medical Affairs and Pharmacovigilance, most recently serving as Vice President of Global Medical Affairs at Otsuka Pharmaceutical.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812088929/en/

"Medical Affairs teams face more pressure than ever to stay compliant while coordinating across functions and regions. BP Logix understands these challenges deeply." - Rob Kaper, BP Logix Life Sciences Strategic Advisory Board

As a Strategic Advisor, Dr. Kaper will provide guidance to the BP Logix executive team on product innovation, go-to-market strategy, and deepening industry alignment across medical and regulatory affairs teams in the pharmaceutical sector.

“Dr. Kaper has built and led medical affairs organizations on both sides of the Atlantic—guiding teams through complex transitions like post-acquisition integrations, safety crises, and Corporate Integrity Agreements,” said Girish Pashilkar, CEO of BP Logix. “His expertise in scaling medical teams, launching products, and navigating regulatory complexity is directly aligned with the challenges our customers face. We’re thrilled to welcome him aboard.”

Throughout his career, Dr. Kaper has overseen strategic planning and execution for new product launches and lifecycle management, working cross-functionally with regulatory, clinical, and commercial teams to drive global success.

“Medical Affairs teams face more pressure than ever to stay compliant while coordinating across functions and regions. They need systems that support collaboration, maintain audit readiness, and free them from the drag of manual processes,” said Dr. Kaper. “BP Logix understands these challenges deeply. I’m excited to collaborate with a company committed to building purpose-built technology for the way Medical Affairs teams actually work.”

Dr. Kaper joins BP Logix’s Strategic Advisory Board alongside Dr. Jethro Ekuta, deepening the company’s commitment to partnering with seasoned life sciences leaders who bring practical, real-world insights from medical and regulatory affairs.

“We are building our Advisory Board with seasoned, respected leaders who bring practical insights and help us strengthen both our product and our credibility in this conservative, high-stakes space,” added Pashilkar. “Dr. Kaper’s voice will be instrumental as we shape the future of review and approval automation for Medical Affairs.”

To learn more about BP Logix and its life sciences solutions for publication management, medical information requests, investigator-initiated studies, MLR reviews, and global clearance workflows, visit www.bplogix.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250812088929/en/

Media contact: Catie Leary, [email protected]

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY HEALTH TECHNOLOGY SOFTWARE NETWORKS INTERNET MANAGED CARE PHARMACEUTICAL HEALTH DATA MANAGEMENT ARTIFICIAL INTELLIGENCE

SOURCE: BP Logix

Copyright Business Wire 2025.

PUB: 08/12/2025 08:00 AM/DISC: 08/12/2025 07:59 AM

http://www.businesswire.com/news/home/20250812088929/en